KROS — KEROS THERAPEUTICS INC

Ownership history in HAP Trading, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which HAP Trading, LLC reported a position in KEROS THERAPEUTICS INC (KROS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2025 Q1)
Avg. % of fund
0.02%
First filed
2025 Q1
Last filed
2025 Q1
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q1 ADDED 80,000 +57,449 +254.8% 0.01% $66.0M $10.19
2025 Q1 INITIATED 22,551 — — 0.02% $229.8M $10.19
% of Fund (quarterly)    KROS price (monthly, adj. close)

Other funds also holding KROS

As of 2025 Q4 — sorted by position size

Rangeley Capital, LLC 1.64% Madison Avenue Partners, LP 3Y 0.72% ORBIMED ADVISORS LLC 3Y 7Y 0.33% Nantahala Capital Management, LLC 3Y 7Y 0.24% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.21% Quantedge Capital Pte Ltd 3Y 0.19% OXFORD ASSET MANAGEMENT LLP 3Y 7Y 0.18% EJF Capital LP 3Y 7Y 0.17% Nantahala Capital Management, LLC 3Y 7Y 0.17% PDT Partners, LLC 3Y 7Y 0.15%
← Back to HAP Trading, LLC Holdings